NeuCode proteomics reveals BAP1 regulation of metabolism


Collaborating Investigator/s

Donald Kirkpatrick and Anwesha Dey (Genentech, South San Francisco, CA)



In this project we introduced neutron-encoded (NeuCode) amino acid labeling of mice as a strategy for multiplexed proteomic analysis in vivo. Using NeuCode, we characterized an inducible knockout mouse model of Bap1, a tumor suppressor and deubiquitinase whose in vivo roles outside of cancer are not well established. NeuCode proteomics revealed altered metabolic pathways following Bap1 deletion, including profound elevation of cholesterol biosynthetic machinery coincident with reduced expression of gluconeogenic and lipid homeostasis proteins in liver. Bap1 loss increased pancreatitis biomarkers and reduced expression of mitochondrial proteins. These alterations accompany a metabolic remodeling with hypoglycemia, hypercholesterolemia, hepatic lipid loss, and acinar cell degeneration. Liver-specific Bap1 null mice present with fully penetrant perinatal lethality, severe hypoglycemia, and hepatic lipid deficiency. This work revealed Bap1 as a metabolic regulator in liver and pancreas, and it established NeuCode as a reliable proteomic method for decip hering in vivo biology.


CellReports, 16 (2016) 583-595. doi:10.1016/j.celrep.2016.05.096